Lia E Perez MD

Hematology•Tampa, FL

Assistant Professor, Oncologic Sciences, USF-Morsani

Request appointment

12902 Usf Magnolia DrTampa, FL 33612
Book by Phone+1(659) 247-5411

Overview of Dr. Perez

Dr. Lia Perez is a hematologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from University of Buenos Aires and has been in practice 35 years. Dr. Perez accepts several types of health insurance, listed below. She is one of 60 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Hematology. She has more than 80 publications and over 500 citings.

Education & Training

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
Brooklyn Hospital CenterResidency, Internal Medicine, 1994 - 1997
University of Buenos AiresClass of 1991

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2003 - 2027
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2016-2017
CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2016-2017
CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2016-2017

Clinical Trials

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
TERMINATED
PHASE2
Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma Start of enrollment: 2009 Jun 18
COMPLETED
PHASE2
Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)
COMPLETED
PHASE1, PHASE2

Publications & Presentations

PubMed

Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis.
Joseph A Pidala, Jongphil Kim, Jose Laborde, Samantha Knott, Krishnakar Mogili
Blood Advances. 2026-07-21
Expanded antigen-specific donor regulatory T cells for GVHD prevention.
Joseph A Pidala, Nicoletta Cieri, Michael J Schell, Xiaofei Song, Yiren Shao
Blood. 2026-06-18
Single center evaluation of a composite risk assessment model to predict non-relapse mortality following allogeneic hematopoietic cell transplantation (HCT).
Reshma Ramlal, Jongphil Kim, Zachary Thompson, Leonel Ochoa-Bayona, Asmita Mishra
Bone Marrow Transplantation. 2026-06-01

Abstracts/Posters

CD34+ Cell Dose Influences Survival after Allogeneic Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide
Lia Perez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts Outcome
Lia Perez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Impact of TBI-Based Conditioning Regimen on Outcomes of Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplant: Systematic Revi...
Lia Perez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Grant Support

Clonogenic Characterization Of Myeloma Progenitor CellsNational Cancer Institute2010–2011
Thrombocytopoiesis In Hematopoietic TransplantationNational Heart, Lung, And Blood Institute2005–2009

Insurance Accepted

Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment